Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024Oral PresentationsOpen Access

03 Long lasting alterations of the immunophenotype and cytokine signature of DLBCL survivors results in persisting immune dysfunction

View Full Paper
Ask AI
Bookmark
Share

Authors

GBGiulia BenintendeRPRichard PelzlKWKristin Wendland

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Benintende et al. (2024) studied this question.

synapsesocial.com/papers/68e76604b6db6435876db97bhttps://doi.org/10.1136/jitc-2024-itoc10.8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immune dysregulation in newly diagnosed DLBCL: From clinical observations to molecular mechanisms2025
  2. 2Abstract PR02: Aging-associated molecular and cellular alterations determine the biology and clinical characteristics of DLBCL in elderly patients2024
  3. 3Abstract PR002: Bcl6 -driven Cd70 -deficient Diffuse large B-cell lymphomas originate from innate-like cells with blunted CD4+ cytotoxic T-cell immune surveillance2026
  4. 4Multimodal profiling identifies CD4+CXCR5+PD-1– Tfh cells as prognostic and predictive biomarkers in diffuse large B-cell lymphoma2025
  5. 5Abstract 7944: Tumor immune micro-environment (TME) dynamics in longitudinal diffuse large B-cell lymphoma (DLBCL) cases from diagnosis to RCHOP relapse2026